The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - BioNTech; CureVac; GlaxoSmithKline; Roche
Efficacy of FOLFIRI plus bevacizumab versus FOLFIRI plus cetuximab in RAS-mutant metastatic colorectal cancer: Final update on patients with RAS-mutant metastatic colorectal cancer treated in FIRE-3.
 
Lena Weiss
Honoraria - Roche; SERVIER
Consulting or Advisory Role - Roche (Inst)
Travel, Accommodations, Expenses - Amgen
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Sanofi; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Cor2Ed; GlaxoSmithKline; Lilly; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Ludwig von Weikersthal
No Relationships to Disclose
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Alexander Kiani
No Relationships to Disclose
 
Ursula Vehling-Kaiser
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Hexal; Lilly; Roche
Speakers' Bureau - Abbvie; Amgen; Boehringer Ingelheim; CSL Behring; Forum for Medical Futher Education; Gilead Sciences; Hexal; Jürgen Schaaf Verlags; Lilly; Merck Serono; Merck Sharp & Dohme; MorphoSys; Octapharm; OnkoInform; Roche; Sirtex Medical
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Frankfurter Institut für Klinische Krebsforschung IKF GmbH; Immutep
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; Eli Lilly Germany; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Immutep; Ipsen; Lilly; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Tobias Heintges
No Relationships to Disclose
 
Christian A. Lerchenmuller
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Gernot Seipelt
No Relationships to Disclose
 
Frank Kullmann
Consulting or Advisory Role - Bayer; Novartis
Research Funding - Celgene
 
Markus H. Moehler
Honoraria - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bayer Schering Pharma; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Idience; Merck Serono; MSD Oncology; Pierre Fabre; Roche/Genentech; Sanofi; Servier; Transcenta; Triptych Health Partners
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; BMS; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD; Nordic Group; SERVIER; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; BeiGene; ESMO; German Cancer Society; Merck Serono; MSD; Roche; Sanofi Pasteur
 
Werner Scheithauer
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Lisa Miller-Phillips
No Relationships to Disclose
 
Arndt Stahler
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Merck KGaA; Roche; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Novocure; Takeda
Travel, Accommodations, Expenses - Amgen; Lilly; Pfizer; Roche
 
Andreas Jung
Consulting or Advisory Role - Biocartis; Roche
Speakers' Bureau - Amgen; AstraZeneca; Bayer Germany
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Halozyme; Janssen; Merck; MSD; Nordic Bioscience; Novartis; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; Sirtex Medical; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience